Docteur FREDERIC MEDINA

Bibliographie

• Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis

  2017

  ArticleTherapeutic Drug Monitoring

• Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

  2017

  ArticleArthritis & rheumatology

• Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis

  2017

  ArticleTherapeutic Drug Monitoring

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

• CENTRE HOSPITALIER DE TROYES

  101 Avenue ANATOLE FRANCE, 10003 Troyes

  ☎ 0325494949Hospitalier🏥 Centre CH ↗🏥 Voir cet établissement

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Vidéos & interventions (12)

Source YouTube · recherche par nom (homonymes possibles).

• 0:57

  Je n’avais plus que 5 % de capacité pulmonaire…

  PureSanté · 2 k vues

• 0:53

  5 % de capacité pulmonaire… et le cœur comprimé

  PureSanté · 987 vues

• 24:43

  “Si je m’allonge, je meurs” : Frédéric Médina raconte sa sortie de corps en détails (EMI)

  PureSanté · 7 k vues

• 7:53

  Le témoignage de Frédéric Medina, qui a vécu une expérience de mort imminente

  Touche pas à mon poste ! · 92 k vues

• 2h04

  Cécile Cloulas Comment leur mort a changé leur vie

  Frédéric Médina · 635 vues

• 1h34

  3 EMI NDE Expériences de mort imminente Le retour

  Frédéric Médina · 3 k vues

• 42:02

  L'expérience de mort imminente de Frédéric Médina

  * L' INNOMMABLE * · 2 k vues

• 1h34

  Si on parlait de la Mort (7)

  Frédéric Médina · 755 vues

• 11:08

  EMI/NDE je n'ai pas halluciné ya bien une cuisine à côté de la salle d'opération

  Frédéric Médina · 10 k vues

Articles de presse (1)

Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).

• «Elle concerne une femme sur cinq après 50 ans» : souffrez-vous d’ostéoporose sans le savoir ? - L'Est éclair

  📰 L'Est éclair · 15/10/2024

  <a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNS3JTNEljUGZNRk1PX1J2YWQ3N29CdzRkNTJlOUtPY2U3enI2OEZzT0YzQmxFTWdwZzFiVThUYjJLSWotenJBOHNDMll2Y2tzY2NsRlYtZUljaUFwa3A4QkFFMTdGSlJYRjA2QmwyS1pXdGQ3eUg5aHB5bjF4aTloOWxWZFBfM3RaRFBTY3hBNkN5YjJDS3BqeHBRQzVueUpWNzFCaENEMFdFY1N5Q3Q2VTNISy1wYWxzR0

Top publications · les plus citées

• 1

  Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases

  Medicine · 2005

  📚 121 citations🎯 RCR 3.42Top 13% NIH🔓 Open Access📄 PDF gratuit ↗
• 2

  Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy

  The American journal of medicine · 1997

  📚 98 citations🎯 RCR 4.25Top 10% NIH
• 3

  Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry)

  The Journal of rheumatology · 2009

  📚 92 citations🎯 RCR 3.06Top 16% NIH🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  Objective.To describe the clinical and immunologic characteristics of a large series of patients with systemic autoimmune diseases (SAD) associated with chronic hepatitis C virus (HCV) infection.Methods.The HISPAMEC Registry is a multicenter international study group dedicated to collecting data on patients diagnosed with SAD with serological evidence of chronic HCV infection. The information sources are cases reported by physicians of the HISPAMEC Study Group and periodic surveillance of reported cases by a Medline search updated up to December 31, 2007.Results.One thousand twenty HCV patients with SAD were included in the registry. Patients were reported from Southern Europe (60%), North America (15%), Asia (14%), Northern Europe (9%), South America (1%), and Australia (1%). Countries reporting the most cases were Spain (236 cases), France (222 cases), Italy (144 cases), USA (120 cases), and Japan (95 cases). The most frequently reported SAD were Sjögren’s syndrome (SS; 483 cases), rheumatoid arthritis (RA; 150 cases), systemic lupus erythematosus (SLE; 129 cases), polyarteritis nodosa (78 cases), antiphospholipid syndrome (59 cases), inflammatory myopathies (39 cases), and sarcoidosis (28 cases). Twenty patients had 2 or more SAD. Epidemiological data were available in 677 cases. Four hundred eighty-seven (72%) patients were female and 186 (28%) male, with a mean age of 49.5 ± 1.0 years at SAD diagnosis and 50.5 ± 1.1 years at diagnosis of HCV infection. The main immunologic features were antinuclear antibody (ANA) in 61% of patients, rheumatoid factor (RF) in 57%, hypocomplementemia in 52%, and cryoglobulins in 52%. The main differential aspect between primary and HCV-related SAD was the predominance of cryoglobulinemic-related markers (cryoglobulins, RF, hypocomplementemia) over specific SAD-related markers (anti-ENA antibodies, anti-dsDNA, anti-cyclic citrullinated peptide) in patients with HCV.Conclusion.In the selected cohort, the SAD most commonly reported in association with chronic HCV infection were SS (nearly half the cases), RA and SLE. Nearly two thirds of SAD-HCV cases were reported from the Mediterranean area. In these patients, ANA, RF and cryoglobulins are the predominant immunological features.

Publications scientifiques (31) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche